-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In response to the news that the oncologists of the Third Hospital of Beijing Medical University reported on the shady tumor treatment, Jiao Yahui, director of the Medical Administration and Hospital Administration of the National Health Commission, said at a press conference on April 27 that after expert and peer review, he believed that during the entire treatment process, The principle of treatment is basically in line with the norms.
In addition, He Jie, academician of the Chinese Academy of Sciences and director of the National Cancer Center, said at the meeting that at present, the individual differences in cancer patients are very obvious, and the treatment is also very complicated.
But Hejie emphasized that “Clinical pharmacological institutions and ethics committees should strictly supervise these clinical studies on super-indications and super-therapeutic guidelines.
